HHS Drug Forum: CMS' Slavitt Highlights Price Transparency As One Key To Affordability
This article was originally published in The Pink Sheet Daily
Executive Summary
In the HHS-sponsored "listen and learn" forum about pharmaceutical innovation, access and affordability, CMS chief Slavitt outlined three "domains" that he wants to address: value and value-based payments; pricing information transparency and availability; and government incentives and hurdles.